Search earnings tickers

VRTX

2025Q4AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-02-12 · Fiscal end 2025-12-31 · Features as of 2026-02-12

← Earnings history

Street

Consensus EPS5.15

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move3.7%

IV front—

P/C full—

P/C front—

Features as of2026-02-12

Run-up

Close—

Ret 5d+1.4%

Ret 10d-2.2%

Ret 20d+3.4%

Ret 30d+2.5%

Print

Actual EPS

5.03Miss

Estimated EPS5.15

Actual revenue

3.2B

Surprise %-2.3%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+4.2%

Implied vs actual

Implied 3.7%Actual 1.4%

Gap reaction+1.4%

Day result+5.7%

Next-day upYes

Realized / IV0.38×

Post tape

Post 5d-2.1%

Post 10d-1.1%

Post volume2.9M

Vol ×10d1.92×

Vol ×20d1.86×

Post range6.8%